Whiteside SP, et al. - In view of the increase in the use of medications for pediatric psychiatric disorders, researchers examined the 5-year course of medication treatment in children with newly diagnosed anxiety disorders. From a tertiary medical center, provider billing and prescription ordering records were reviewed to assess children (aged 7–17 years) newly diagnosed with an anxiety disorder with their psychopharmacologic treatment from 2010 through 2015. Among the 108 patients identified, 73.1% were provided treatment at least once over the 5-year period; 41.7% were given medications from more than 1 class. The medication was continually taken by 50% (27/54) of patients for 5 years among those who received a prescription. Within the subset of patients who were medication-naive at the beginning of the observation period and were still in high school during year 5, this estimate rose to 71% (5/7). These findings suggest that clinical practice does not accurately reflect guidelines that suggest discontinuation of medication after symptom remission and a limited period of stability.